Last Updated: June 30, 2026

CLINICAL TRIALS PROFILE FOR PALYNZIQ

✉ Email this page to a colleague

All Clinical Trials for PALYNZIQ

Subscribe to access the full database, or Start Trial
Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT06780332 ↗	Rapid Drug Desensitization Study in Adults Experiencing Hypersensitivity Reactions to Palynziq	RECRUITING	BioMarin Pharmaceutical	PHASE4	2025-01-01	The purpose of this study is to determine if rapid drug desensitization (RDD) to Palynziq will improve drug tolerability and treatment persistence in adult patients on commercial Palynziq experiencing hypersensitivity reactions (HSRs) leading to treatment interruption or reduction of dose or dosing frequency. See Section 10.8 for full list of HSR preferred terms. Study details include: * Study duration: Up to 30 weeks (up to 6 weeks for Screening, then RDD, and 24 weeks of follow-up) * RDD duration: 1 day * Palynziq dosing/follow-up duration: 24 weeks * Palynziq dosing frequency: Individualized
>Trial ID	>Title	>Status	>Sponsor	>Phase	>Start Date	>Summary

Clinical Trial Conditions for PALYNZIQ

Condition Name

Chart
Table

Condition Name for PALYNZIQ
Intervention	Trials
Phenylketonuria	1
PKU	1
[disabled in preview]	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Condition MeSH

Chart
Table

Condition MeSH for PALYNZIQ
Intervention	Trials
Phenylketonurias	1
[disabled in preview]	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Locations for PALYNZIQ

Trials by Country

Map
Table

Trials by Country for PALYNZIQ
Location	Trials
United States	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Trials by US State

Map
Table

Trials by US State for PALYNZIQ
Location	Trials
Maryland	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Progress for PALYNZIQ

Clinical Trial Phase

Chart
Table

Clinical Trial Phase for PALYNZIQ
Clinical Trial Phase	Trials
PHASE4	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Status

Chart
Table

Clinical Trial Status for PALYNZIQ
Clinical Trial Phase	Trials
RECRUITING	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Sponsors for PALYNZIQ

Sponsor Name

Chart
Table

Sponsor Name for PALYNZIQ
Sponsor	Trials
BioMarin Pharmaceutical	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Sponsor Type

Chart
Table

Sponsor Type for PALYNZIQ
Sponsor	Trials
INDUSTRY	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.